0
0
7/14/23 at 3:20pm
Organization
CNBC
Author
Annika Kim Constantino
44 words
0
Comments
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.
You are the first to view
https://www.cnbc.com/2023/07/14/eli-lilly-to-acquire-obesity-drug-maker-versanis-for-1point9-billion.html
Create an account
or login to join the discussion